Gain critical knowledge on the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a groundbreaking proposed rule from CMS aimed at transforming Medicare Part B drug payment through international price benchmarking. This course details the GLOBE Model’s structure, targeted drug categories, mandatory manufacturer obligations, new rebate calculations, and quality monitoring strategies. Learn how international pricing benchmarks are set, how coinsurance is recalculated for beneficiaries, and what compliance means for manufacturers, providers, and policy professionals. Prepare to understand operational requirements, financial impacts, and opportunities for public participation that could shape the final rule.
In this course you will learn the following:
* Understand the intent and goals of the GLOBE Model.
* Identify the key provisions and structure of the proposed rule.
* Recognize the opportunities for public participation and comment.
* Anticipate potential changes and the evolving nature of the rule.
* Comprehend the expected impacts on stakeholders, including manufacturers, providers, beneficiaries, and small entities.
